Immuron Ltd current report, Q3 FY2019

Business Context and Reporting Period

Company: Immuron Ltd (Foreign Private Issuer)

Filing Type: Form 6-K

Reporting Period: August 2019 (Specific date: August 16, 2019)

Context: This filing serves to report a public announcement made to the Australian Securities Exchange (ASX) regarding a "Non-Deal Investor Roadshow Presentation" conducted in August 2019. The filing includes the presentation as an exhibit but does not contain a full financial report.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural report referencing an attached presentation rather than a financial statement.

Material Changes

No material financial changes or operational updates are detailed within the text of this Form 6-K. The filing solely references the dissemination of investor presentation materials.

Guidance, Outlook, and Risks

Management Commentary: The filing notes the publication of a "Non-Deal Investor Roadshow Presentation." Specific guidance, outlook, or management commentary contained within that presentation is not summarized in the text of this filing.

Risks and Contingencies: No specific risks or contingencies are disclosed in the body of this report.

Unusual Items: None reported in the text.

Investor Verification Checklist

  • Review the attached Exhibit 99.1 ("Non-Deal Investor Roadshow Presentation August 2019") for detailed financial data and strategic outlook.
  • Verify the company's current cash runway and burn rate, as this filing does not disclose liquidity figures.
  • Confirm the status of clinical trials or product development pipelines, which are likely discussed in the roadshow presentation but not in this summary filing.
  • Check subsequent filings for any updates on the investor roadshow outcomes or capital raising activities.